Navnath S. Gavande

Eugene Applebaum College of Pharmacy and Health Sciences

Also affiliated with Wayne State University, The Barbara Ann Karmanos Cancer Institute, Detroit R&D (United States)

Biochemistry, Genetics and Molecular BiologyNeuroscienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Ubiquitin-Specific Protease Inhibitors for Cancer Therapy: Recent Advances and Future Prospects”.

Ubiquitin-Specific Protease Inhibitors for Cancer Therapy: Recent Advances and Future Prospects

Biomolecules(2025)10.3390/biom15020240

N/A

0.457DataRank · unranked

20 citations

Sara I. Khalil, Komal Bhayekar, Narva Deshwar Kushwaha, Amirreza Samarbakhsh, Sadaf Dorandish +5 more

Discovery and Development of Novel DNA-PK Inhibitors by Targeting the unique Ku-DNA Interaction

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.24.261875

N/A

0DataRank · unranked

4 citations

Pamela S. VanderVere-Carozza, Katherine S. Pawelczak, Tyler L. Vernon, Leslyn A. Hanakahi, Matthew Summerlin +7 more

Chemical exhaustion of RPA in cancer treatment

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.30.404640

N/A

0DataRank · unranked

4 citations

Katherine S. Pawelczak, Navnath S. Gavande, Shadia I. Jalal, Karen E. Pollok, Elmira Ekinci +4 more

Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair

Frontiers in Oncology(2022)10.3389/fonc.2022.850883

N/A

0DataRank · unranked

24 citations

Amirreza Samarbakhsh, Athira Pillai, Pamela S. VanderVere-Carozza, Hariprasad Aruri, Deepti S. Pandey +4 more

In Vivo Targeting Replication Protein A for Cancer Therapy

Frontiers in Oncology(2022)10.3389/fonc.2022.826655

N/A

0DataRank · unranked

23 citations

Navnath S. Gavande, Shadia I. Jalal, Karen E. Pollok, Elmira Ekinci, Joshua Heyza +5 more

Senescence Associated Secretory Proteins Induced in Lung Adenocarcinoma by Extended Treatment with Dexamethasone Enhance Migration and Activation of Lymphocytes

Research Square(2022)10.21203/rs.3.rs-1874725/v1

N/A

0DataRank · unranked

1 citations

Rayna Rosati, Hirva Mamdani, Robert E. Wright, Zahin Hussain, Aroma Naeem +5 more

PROTAC’ing oncoproteins: targeted protein degradation for cancer therapy

Molecular Cancer(2023)10.1186/s12943-022-01707-5

N/A

0DataRank · unranked

106 citations

Deepti S. Pandey, Evan Malin, Hussein W. Kansou, Sahil Arora, Raj Kumar +2 more

Targeting the Epidermal Growth Factor Receptor with Molecular Degraders: State-of-the-Art and Future Opportunities

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.2c01242

N/A

0DataRank · unranked

39 citations

Joydeep Chatterjee, Kiran T. Patil, Sahil Arora, Madhurendra K. Katiyar, Manvendra Kumar +7 more

Ku–DNA binding inhibitors modulate the DNA damage response in response to DNA double-strand breaks

NAR Cancer(2023)10.1093/narcan/zcad003

N/A

0DataRank · unranked

8 citations

Navnath S. Gavande, Pamela S. VanderVere-Carozza, Katherine S. Pawelczak, Joseph R. Dynlacht, Joy Garrett +2 more

Enhanced safety and efficacy profile of CD40 antibody upon encapsulation in pHe-triggered membrane-adhesive nanoliposomes

Nanomedicine(2024)10.1080/17435889.2024.2446008

N/A

0DataRank · unranked

4 citations

Prahlad Parajuli, Duy Luong, Samaresh Sau, Lisa Polin, Seong Ho Kim +4 more

Impact of Optimized Ku–DNA Binding Inhibitors on the Cellular and In Vivo DNA Damage Response

Cancers(2024)10.3390/cancers16193286

N/A

0DataRank · unranked

3 citations

Narva Deshwar Kushwaha, Dineshsinha Chauhan, Karim Ben Ali Gacem, Joy Garrett, Joseph R. Dynlacht +4 more

An overview of the development of pharmacotherapeutics targeting SARS-CoV-2

Drug Discovery Today(2024)10.1016/j.drudis.2024.104126

N/A

0DataRank · unranked

2 citations

Ian Hay, Amirreza Samarbakhsh, Mel Bedi, Arun K. Iyer, Navnath S. Gavande +1 more

Evolution of structure-guided drug design strategies targeting mutations in codon 12 of KRAS

RSC Medicinal Chemistry(2025)10.1039/d5md00169b

N/A

0DataRank · unranked

5 citations

Komal Bhayekar, Anuradha Singh, Narva Deshwar Kushwaha, Evan Malin, Sara Serafimovski +4 more

Structure-Based Design and Development of 2-Oxindole Derivatives as Next Generation Ku-DNA Binding Inhibitors (Ku-DBi’s) for Cancer Therapy.

ChemRxiv(2025)10.26434/chemrxiv-2025-bp68g

N/A

0DataRank · unranked

0 citations

Dineshsinha Chauhan, Pamela L. Mendoza-Munoz, Joseph Engel, Hariprasad Aruri, Ladislau C. Kovari +3 more

Discovery and development of novel DNA-PK inhibitors by targeting the unique Ku–DNA interaction

Nucleic Acids Research(2020)10.1093/nar/gkaa934

N/A

0DataRank · unranked

48 citations

Pamela S. VanderVere-Carozza, Katherine S. Pawelczak, Pamela L Mendoza-Munoz, Tyler L. Vernon, Leslyn A. Hanakahi +8 more

Design, synthesis, and structure–activity relationship studies of 4-substituted phenylpyrazolidinone derivatives as potent Ku70/80 targeted DNA-PK inhibitors

RSC Medicinal Chemistry(2025)10.1039/d5md00263j

N/A

0DataRank · unranked

0 citations

Pamela S. VanderVere-Carozza, Tyler L. Vernon, Pamela L. Mendoza-Munoz, Jitender Dev Gaddameedi, Karim Ben Ali Gacem +5 more